paclitaxel has been researched along with Prosthesis Durability in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (32.26) | 29.6817 |
| 2010's | 42 (67.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuellas, C; Estévez, R; Fernández-Vázquez, F; López-Benito, M; Pérez de Prado, A | 1 |
| Fukutomi, M; Funayama, H; Kario, K; Oba, Y | 1 |
| Ali, ZA; Ben-Yehuda, O; Gkargkoulas, F; Gore, AK; Konigstein, M; Madhavan, MV; Maehara, A; McAndrew, T; Mehdipoor, G; Rahim, HM; Redfors, B; Shlofmitz, E; Srdanovic, I; Stone, GW | 1 |
| Brener, SJ; Brodie, BR; Guagliumi, G; Inaba, S; Kellett, MA; Maehara, A; Mehran, R; Mintz, GS; Stone, GW; Witzenbichler, B; Xu, K; Yakushiji, T | 1 |
| Beschorner, U; Brechtel, K; Dake, MD; Kultgen, PL; Noory, E; Rastan, A; Tepe, G; Zeller, T | 1 |
| de Boer, SW; de Vries, JP; Elgersma, O; Fioole, B; Heyligers, JM; Karimi, A; Lohle, PN; Nolthenius, RP; van den Heuvel, DA; Vos, JA; Vroegindeweij, D | 1 |
| Awata, M; Iida, O; Ishihara, T; Nanto, S; Shiraki, T; Uematsu, M | 1 |
| Airoldi, F; Baldino, G; Clerici, G; Faglia, E; Gori, A; Latib, A; Losa, S; Mortola, P; Tavano, D | 1 |
| Basavarajaiah, S; Carlino, M; Chieffo, A; Colombo, A; Fujino, Y; Godino, C; Hasegawa, T; Ielasi, A; Latib, A; Montorfano, M; Naganuma, T; Nakamura, S; Shannon, J; Takagi, K | 1 |
| Alvarez-Ossorio, MP; Bellido, FM; de Lezo Cruz-Conde, JS; de Lezo Herrerosde Tejada, JS; Fernández-Aceytuno, AM; Pavlovic, D; Pineda, SO; Romero Moreno, MÁ; Saint-Gerons, JM; Toledano Delgado, FJ | 1 |
| Brener, SJ; Caputo, R; Cutlip, DE; Kereiakes, DJ; Mastali, K; Newman, W; Rizvi, A; Simonton, CA; Smith, RS; Stone, GW; Wang, JC; Ying, SW | 1 |
| Alfonso, F; Bethencourt, A; Cárdenas, A; Cequier, A; Dominguez, A; Fernández, C; García Del Blanco, B; García-Touchard, A; Gómez-Recio, M; Gonzalo, N; Iñiguez, A; Jiménez-Quevedo, P; López-Mínguez, JR; Macaya, C; Mainar, V; Martí, V; Masotti, M; Melgares, R; Moreno, R; Moreu, J; Pérez-Vizcayno, MJ; Sanchís, J; Seidelberger, B; Velázquez, MT; Zueco, J | 1 |
| Cohen, DJ; Han, JK; Hwang, SS; Kandzari, DE; Kang, DY; Kang, HJ; Kang, SH; Kim, HS; Koo, BK; Lim, WH; Oh, BH; Park, KT; Park, KW; Park, YB | 1 |
| Egami, Y; Makino, N; Mori, N; Nakamura, D; Nishino, M; Shutta, R; Tanaka, A; Taniike, M; Tanouchi, J; Yoshimura, T | 1 |
| Ahmed, I; Diamantopoulos, A; Karunanithy, N; Katsanos, K; Kitrou, P; Padayachee, S; Parthipun, A; Zayed, H | 1 |
| Chen, F; Loh, JP; Omar, A; Pendyala, LK; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
| Akashi, YJ; Harada, T; Kamijima, R; Kongoji, K; Koyama, K; Kuwata, S; Mitarai, T; Nakano, E; Tanabe, Y; Yamazaki, H; Yoneyama, K | 1 |
| Ansel, GM; Dake, MD; Jaff, MR; Kichikawa, K; Kimura, T; O'Leary, EE; Ohki, T; Ragheb, AO; Snyder, SA; Yokoi, H | 1 |
| Allocco, DJ; Ball, M; Bertolet, B; Cannon, LA; Dauber, I; Dawkins, KD; Foster, M; Kereiakes, DJ; Nersesov, AY; Underwood, PL | 1 |
| Dohi, Y; Fukuda, Y; Ikenaga, H; Ishibashi, K; Kihara, Y; Kurisu, S | 1 |
| Baumgartner, S; Jüni, P; Meier, B; Räber, L; Stefanini, GG; Taniwaki, M; Wenaweser, P; Windecker, S; Zanchin, T; Zaugg, S | 1 |
| Bernelli, C; Guagliumi, G; Komukai, K; Sirbu, V | 1 |
| Kret, MR; Lee, JT; Tran, K; Ullery, BW | 1 |
| Allemann, S; Cervinka, P; Chechi, T; De Carlo, M; de Lezo, JS; Diem, P; Dirksen, MT; Erglis, A; Goy, JJ; Jüni, P; Kastrati, A; Kelbaek, H; Leon, MB; Meier, B; Menichelli, M; Morice, MC; Ortolani, P; Park, SJ; Pfisterer, ME; Sabaté, M; Schalij, MJ; Schömig, A; Spaulding, C; Stettler, C; Stone, GW; Suttorp, MJ; Vermeersch, P; Wandel, S; Windecker, S | 1 |
| Kadota, J; Miyamoto, K; Tamura, A; Watanabe, T | 1 |
| Ahn, Y; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Sim, DS | 1 |
| Bergheanu, SC; Hassan, AK; Plevier, JW; Schalij, MJ; Snoep, JD; Stijnen, T; van der Hoeven, BL; Wouter Jukema, J | 1 |
| Byrne, RA; Dibra, A; Eberle, S; Iijima, R; Kastrati, A; Mehilli, J; Ndrepepa, G; Schömig, A | 1 |
| Berger, I; Kurz, P; Lopez-Benitez, R; Radeleff, B; Richter, GM; Sommer, C; Stampfl, S; Stampfl, U; Thierjung, H | 1 |
| Canan, T; Lee, MS | 1 |
| Alexopoulos, D; Damelou, A; Davlouros, PA; Karantalis, V; Mavronasiou, E; Nikokiris, G; Tsigkas, G; Xanthopoulou, I | 1 |
| Ball, T; Foerst, J; Kaplan, AV | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Chung, WY; Kang, HJ; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Park, JJ; Park, KW; Park, YB; Seo, JB; Yang, HM; Yeon, TJ | 1 |
| Finn, AV; Kolodgie, FD; Ladich, ER; Nakazawa, G; Virmani, R; Vorpahl, M | 1 |
| Kovarnik, T; Mintz, GS; Sonka, M | 1 |
| Almasood, AS; Džavík, V; Freixa, X; Khan, SQ; Mackie, K; Osherov, A; Seidelin, PH; Wainstein, R | 1 |
| Cook, S; Eberli, FR; Eshtehardi, P; Jüni, P; Kalesan, B; Lüscher, T; Meier, B; Moschovitis, A; Räber, L; Seiler, C; Togni, M; Vogel, R; Wenaweser, P; Windecker, S | 1 |
| Albertal, M; Belardi, JA | 1 |
| Birkemeyer, R; Brachmann, J; Breithardt, OA; Brugger, A; Daniel, WG; Kurowski, V; Lonke, S; Nguyen, TV; Ohlow, M; Rittger, H; Schmidt, M; Sinha, AM; Thiele, H; von Cranach, M; Waliszewski, M; Wöhrle, J; Zimmermann, S | 1 |
| Byrne, RA; Kastrati, A; King, L; Mehilli, J; Pache, J; Schömig, A | 1 |
| Biondi-Zoccai, G; Briguori, C; D'Ascenzo, F; De Waha, A; Della Riva, D; Kaiser, C; Kedhi, E; Kim, HS; Kimura, T; Kirtane, AJ; Leon, MB; Marullo, A; Palmerini, T; Sabatè, M; Sangiorgi, D; Sardella, G; Smits, PC; Stettler, C; Stone, GW | 1 |
| Capodanno, D; Facchin, M; Lettieri, C; Mancone, M; Meliga, E; Menozzi, A; Musumeci, G; Saia, F; Tamburino, C; Tarantini, G | 1 |
| Almasood, AS; Džavík, V; Freixa, X; Horlick, EM; Ing, D; Khan, SQ; Mackie, K; Osten, M; Overgaard, CB; Seidelin, PH | 1 |
| Gruberg, L; Parikh, PB | 1 |
| Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Kawamori, H; Kozuki, A; Matsumoto, D; Nagoshi, R; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Taniguchi, Y | 1 |
| Bouzamondo, A; Lechat, P; Montalescot, G; Roiron, C; Sanchez, P | 1 |
| Ormerod, O; Schrale, R | 1 |
| Anderson, TJ; Charbonneau, F; Curtis, MJ; Goodhart, DM; Hansen, JL; Knudtson, ML; Spence, FP; Traboulsi, M; Worthley, MI | 1 |
| Choi, CU; Kim, EJ; Kim, JW; Oh, DJ; Park, CG; Rha, SW; Seo, HS; Suh, SY; Wani, SP | 1 |
| Carrozza, JP; Jeremias, A; Wernick, MH | 1 |
| Aragon, J; Forrester, J; Jurewitz, D; Kar, S; Lee, MS; Makkar, RR | 1 |
| Cutlip, DE; D'Agostino, R; Ho, KK; Hsieh, WH; Massaro, JM; Mauri, L | 1 |
| James, SK; Lagerqvist, B; Lindbäck, J; Nilsson, T; Stenestrand, U; Wallentin, L | 1 |
| Colombo, A; Cutlip, DE; Dawkins, KD; Ellis, SG; Fahy, M; Grube, E; Kirtane, AJ; Leon, MB; Mehran, R; Morice, MC; Moses, JW; Pocock, SJ; Schampaert, E; Schofer, J; Stone, GW | 1 |
| Maisel, WH | 1 |
| Colombo, A; Dawkins, KD; Ellis, SG; Grube, E; Koglin, J; Popma, J; Stone, GW | 1 |
| Holmes, DR | 1 |
| Abizaid, AA; Centemero, M; Chaves, A; Costa, Jde R; Feres, F; Mattos, LA; Siqueira, DA; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF | 1 |
| Colombo, A; Latib, A | 1 |
| Allaqaband, S; Bajwa, T; Djelmami-Hani, M; Maddikunta, R; Shaikh, F; Solis, J | 1 |
| Carter, AJ | 1 |
| Gawaz, M; Geisler, T; Goehring-Frischholz, K; Haase, KK; Hartmann, U; Herdeg, C; Zuern, C | 1 |
12 review(s) available for paclitaxel and Prosthesis Durability
| Article | Year |
|---|---|
Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.
Topics: Absorbable Implants; Bayes Theorem; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents; Tubulin Modulators | 2014 |
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.
Topics: Blood Vessel Prosthesis; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2008 |
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Tubulin Modulators | 2010 |
Drug-eluting stent fracture: incidence, contributing factors, and clinical implications.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Equipment Failure Analysis; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Evidence-Based Medicine; Female; Humans; Incidence; Italy; Male; Paclitaxel; Prognosis; Prosthesis Failure; Radiography; Randomized Controlled Trials as Topic; Risk Assessment; Sirolimus; Stents; Survival Analysis; Thrombosis | 2012 |
Forget Mars and venus, men and women are from the same planet after all.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Prosthesis Failure; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Sirolimus; Treatment Outcome | 2012 |
Drug eluting stents: an updated meta-analysis of randomised controlled trials.
Topics: Blood Vessel Prosthesis; Coronary Restenosis; Drug Implants; Humans; Immunosuppressive Agents; Paclitaxel; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome | 2006 |
Drug-eluting stents and stent thrombosis: a cause for concern?
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Stenosis; Coronary Thrombosis; Humans; Immunosuppressive Agents; Incidence; Paclitaxel; Prognosis; Prosthesis Failure; Sirolimus; Stents; Survival Rate | 2006 |
Stent thrombosis in randomized clinical trials of drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Brachytherapy; Combined Modality Therapy; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2007 |
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2007 |
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
Topics: Adolescent; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Cardiac Catheterization; Confidence Intervals; Coronary Angiography; Coronary Stenosis; Drug Administration Routes; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Probability; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Risk Assessment; Stents; Survival Analysis; Taxus; Thrombosis; Time Factors | 2007 |
Incidence of late stent thrombosis with bare-metal, sirolimus, and paclitaxel stents.
Topics: Agnosia; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Drug-Eluting Stents; Global Health; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidence; Metals; Myocardial Ischemia; Paclitaxel; Prosthesis Failure; Sirolimus | 2007 |
12 trial(s) available for paclitaxel and Prosthesis Durability
| Article | Year |
|---|---|
Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial).
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Double-Blind Method; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Failure; Time Factors; Ultrasonography, Interventional; United States | 2013 |
Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
Topics: Aged; Alloys; Angioplasty, Balloon; Ankle Brachial Index; Canada; Cardiovascular Agents; Constriction, Pathologic; Disease-Free Survival; Drug-Eluting Stents; Europe; Exercise Test; Female; Femoral Artery; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Prosthesis Design; Prosthesis Failure; Recurrence; Registries; Republic of Korea; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vascular Patency | 2013 |
Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol fo
Topics: Alloys; Amputation, Surgical; Angiography, Digital Subtraction; Angioplasty, Balloon; Ankle Brachial Index; Arterial Occlusive Diseases; Cardiovascular Agents; Clinical Protocols; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Equipment Failure; Femoral Artery; Hemodynamics; Humans; Hyperplasia; Limb Salvage; Neointima; Netherlands; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Prosthesis Failure; Recurrence; Research Design; Resins, Plant; Single-Blind Method; Stents; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Access Devices | 2013 |
Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Failure; Single-Blind Method; Sirolimus; Treatment Outcome; Tubulin Modulators | 2013 |
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-elutin
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Severity of Illness Index; Sirolimus; Spain; Survival Rate; Treatment Outcome | 2014 |
Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Cardiovascular Agents; Constriction, Pathologic; Disease-Free Survival; Drug-Eluting Stents; Female; Femoral Artery; Germany; Humans; Japan; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Prosthesis Design; Prosthesis Failure; Reproducibility of Results; Research Design; Time Factors; Treatment Outcome; United States; Vascular Patency | 2014 |
Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Bayes Theorem; Chromium; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Patient Selection; Platinum; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Taxus; Time Factors; Treatment Outcome; United States | 2015 |
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Failure; Sirolimus; Tomography, Optical Coherence; Tubulin Modulators | 2015 |
Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Diagnosis, Differential; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prognosis; Prospective Studies; Prosthesis Failure; Time Factors; Tomography, Optical Coherence; Tunica Intima | 2011 |
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
Topics: Aged; Blood Vessel Prosthesis; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidental Findings; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Failure; Single-Blind Method; Sirolimus; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional | 2012 |
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Prosthesis Failure; Single-Blind Method; Treatment Outcome | 2012 |
Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TES
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Polymers; Proportional Hazards Models; Prospective Studies; Prosthesis Failure; Risk Assessment; Sirolimus; Statistics, Nonparametric; Survival Rate; Time Factors; Treatment Outcome | 2013 |
38 other study(ies) available for paclitaxel and Prosthesis Durability
| Article | Year |
|---|---|
Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Metals; Paclitaxel; Prosthesis Failure; Retreatment; Stents; Tomography, Optical Coherence; Treatment Outcome | 2017 |
A drug-coated balloon effectively treated in-stent restenosis due to a stent fracture.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Paclitaxel; Prosthesis Failure | 2018 |
Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trials.
Topics: Antineoplastic Agents; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Failure; Randomized Controlled Trials as Topic; Time Factors; Treatment Failure | 2019 |
Angioscopically apparent large thrombus and uncovered stent struts 6 months after late stent thrombosis of a paclitaxel-coated nitinol drug-eluting stent implanted in the superficial femoral artery.
Topics: Aged; Alloys; Angiography; Angioscopy; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Female; Femoral Artery; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Intermittent Claudication; Paclitaxel; Prosthesis Failure; Thrombosis; Time Factors | 2014 |
Nitinol stents with polymer-free paclitaxel coating for stenosis of failing infrainguinal bypass grafts.
Topics: Aged; Aged, 80 and over; Alloys; Angioplasty, Balloon; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Constriction, Pathologic; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Italy; Lower Extremity; Male; Middle Aged; Paclitaxel; Prosthesis Design; Prosthesis Failure; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency | 2013 |
The impact of main branch restenosis on long term mortality following drug-eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: the Milan and New-Tokyo (MITO) Registry.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Italy; Male; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Failure; Registries; Retrospective Studies; Survival Rate; Time Factors; Tokyo; Treatment Outcome | 2014 |
Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Stenosis; Cross-Sectional Studies; Drug-Eluting Stents; Equipment Failure Analysis; Everolimus; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Prosthesis Failure; Sensitivity and Specificity; Sirolimus; Time Factors; Tomography, Optical Coherence | 2014 |
Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Cross-Sectional Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Failure; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Paclitaxel-coated balloons for failing peripheral bypass grafts: the BYPACS study.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angiography, Digital Subtraction; Angioplasty, Balloon; Blood Flow Velocity; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Constriction, Pathologic; Drug Carriers; Equipment Design; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Limb Salvage; London; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Peripheral Arterial Disease; Proportional Hazards Models; Prospective Studies; Prosthesis Failure; Regional Blood Flow; Reoperation; Risk Factors; Time Factors; Treatment Failure; Ultrasonography, Doppler, Duplex; Vascular Access Devices; Veins | 2014 |
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Retrospective Studies; Severity of Illness Index; Sirolimus; Survival Analysis; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment | 2014 |
Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Vessels; Humans; Male; Neointima; Paclitaxel; Prosthesis Failure; Stents; Tomography, Optical Coherence | 2014 |
Slow-flow phenomenon after Paclitaxel-coated balloon angioplasty: findings from optical coherence tomography and coronary angioscopy.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Angioscopy; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Monitoring, Physiologic; No-Reflow Phenomenon; Paclitaxel; Prosthesis Failure; Retreatment; Sampling Studies; Severity of Illness Index; Stents; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prosthesis Design; Prosthesis Failure; Retreatment; Thrombectomy; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Critical Illness; Disease-Free Survival; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Humans; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Metals; Middle Aged; Multivariate Analysis; Paclitaxel; Popliteal Artery; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Vascular Patency | 2017 |
Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Prosthesis Failure; Recurrence; Retreatment; Sirolimus | 2010 |
A case of paclitaxel-eluting stent fracture after successful recanalization of chronic total occlusion using a retrograde approach.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Equipment Failure Analysis; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure | 2010 |
Distribution of angiographic measures of restenosis after drug-eluting stent implantation.
Topics: Aged; Blood Vessel Prosthesis; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Failure; Sirolimus; Treatment Outcome; Tubulin Modulators | 2009 |
Paclitaxel-induced arterial wall toxicity and inflammation: part 2--long-term tissue response in a minipig model.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Dose-Response Relationship, Drug; Drug-Eluting Stents; Female; Inflammation; Models, Animal; Paclitaxel; Prosthesis Design; Prosthesis Failure; Swine; Swine, Miniature; Time Factors | 2009 |
Postmortem in situ micro-CT evaluation of coronary stent fracture.
Topics: Adult; Angioplasty, Balloon, Coronary; Autopsy; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Fatal Outcome; Humans; Imaging, Three-Dimensional; Male; Paclitaxel; Prosthesis Design; Prosthesis Failure; Radiographic Image Interpretation, Computer-Assisted; Treatment Outcome; X-Ray Microtomography | 2010 |
Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry.
Topics: Age Factors; Aged; Cardiovascular Agents; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Risk Factors; Sex Factors; Sirolimus | 2011 |
Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Radiography; Registries; Risk Assessment; Sirolimus; Survival Analysis; Time Factors | 2011 |
The late stent malapposition develops also after paclitaxel balloon predilatation before bare-metal stent implantation: case description.
Topics: Catheterization; Coronary Restenosis; Drug-Eluting Stents; Female; Heart Aneurysm; Humans; Middle Aged; Paclitaxel; Prosthesis Failure; Retreatment; Tubulin Modulators | 2011 |
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Ontario; Paclitaxel; Prosthesis Design; Prosthesis Failure; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2012 |
Fixing a broken stent.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Prosthesis Failure; Sirolimus | 2012 |
Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter?: long-term clinical outcome of 2,429-patient multicenter registry.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Patient Safety; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Survival Rate; Time Factors; Treatment Outcome | 2013 |
Choice of stent and outcomes after treatment of drug-eluting stent restenosis in highly complex lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Ontario; Paclitaxel; Patient Selection; Prosthesis Failure; Registries; Retreatment; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Survival Analysis; Treatment Outcome | 2013 |
Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up.
Topics: Aged; Angina Pectoris; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prolapse; Prosthesis Failure; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Thrombosis; Tomography, Optical Coherence | 2013 |
Failure to retrieve undeployed paclitaxel-eluting coronary stents.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Disease; Device Removal; Humans; Paclitaxel; Prosthesis Failure; Reoperation; Retrospective Studies; Stents; Treatment Failure | 2006 |
Registry data evaluating the effectiveness of drug-eluting stents for the treatment of symptomatic in-stent restenosis.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Reoperation; Retrospective Studies; Sirolimus; Stents; Time Factors; Treatment Outcome | 2006 |
Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management?
Topics: Aged; Coronary Restenosis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Sirolimus; Stents | 2007 |
Stent fracture associated with drug-eluting stents: clinical characteristics and implications.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; California; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Research Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Stents; Treatment Outcome | 2007 |
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Registries; Risk; Sirolimus; Stents; Sweden | 2007 |
Unanswered questions--drug-eluting stents and the risk of late thrombosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Device Approval; Drug Delivery Systems; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk; Sirolimus; Stents; United States; United States Food and Drug Administration | 2007 |
Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
Topics: Blood Vessel Prosthesis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prosthesis Failure; Sirolimus; Treatment Outcome; Ultrasonography | 2007 |
Late incomplete stent apposition after drug-eluting stent implantation: a true risk factor or "an innocent bystander"?
Topics: Coronary Thrombosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Postoperative Complications; Prosthesis Failure; Risk Factors; Sirolimus; Time Factors; Tubulin Modulators; Ultrasonography, Interventional | 2008 |
Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cineangiography; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Female; Humans; Incidental Findings; Male; Middle Aged; Odds Ratio; Paclitaxel; Prosthesis Design; Prosthesis Failure; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Wisconsin | 2008 |
Stent strut fracture: seeing is believing.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cineangiography; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Incidental Findings; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk Assessment; Risk Factors; Sirolimus; Stress, Mechanical; Time Factors; Treatment Outcome | 2008 |
Catheter-based local antiproliferative therapy in kissing balloon technique for in-stent stenosis of coronary artery bifurcation lesions.
Topics: Administration, Topical; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Feasibility Studies; Female; Humans; Male; Muscle, Smooth, Vascular; Paclitaxel; Prosthesis Failure; Stents; Treatment Outcome | 2008 |